The Allstate Co. (NYSE:ALL) Shares Sold by Quadrature Capital Ltd

Quadrature Capital Ltd cut its holdings in shares of The Allstate Co. (NYSE:ALL) by 18.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,517 shares of the insurance provider’s stock after selling 10,734 shares during the quarter. Quadrature Capital Ltd’s holdings in Allstate were worth $6,512,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in shares of Allstate by 11.5% during the 3rd quarter. Vanguard Group Inc. now owns 32,270,589 shares of the insurance provider’s stock valued at $3,595,266,000 after acquiring an additional 3,322,673 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Allstate by 46.6% in the 3rd quarter. Invesco Ltd. now owns 4,121,941 shares of the insurance provider’s stock valued at $459,225,000 after purchasing an additional 1,311,095 shares during the last quarter. Wellington Management Group LLP raised its holdings in Allstate by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 3,831,852 shares of the insurance provider’s stock valued at $426,907,000 after buying an additional 77,295 shares during the period. Morgan Stanley lifted its position in Allstate by 16.9% in the third quarter. Morgan Stanley now owns 3,701,607 shares of the insurance provider’s stock valued at $412,396,000 after buying an additional 536,137 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its stake in Allstate by 0.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,629,870 shares of the insurance provider’s stock worth $508,109,000 after buying an additional 27,766 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Stock Up 1.2 %

Shares of Allstate stock traded up $1.94 during trading on Friday, hitting $165.06. 1,351,763 shares of the stock were exchanged, compared to its average volume of 1,248,280. The stock has a market cap of $43.56 billion, a price-to-earnings ratio of 36.44, a price-to-earnings-growth ratio of 1.54 and a beta of 0.50. The firm’s 50-day moving average price is $168.52 and its 200 day moving average price is $157.75. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.36 and a quick ratio of 0.36. The Allstate Co. has a 12-month low of $100.57 and a 12-month high of $177.37.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Thursday, May 2nd. The insurance provider reported $5.13 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.11 by $1.02. Allstate had a return on equity of 14.44% and a net margin of 2.31%. The company had revenue of $15.26 billion during the quarter, compared to the consensus estimate of $12.76 billion. During the same period in the previous year, the business earned ($1.30) EPS. Allstate’s revenue for the quarter was up 10.7% on a year-over-year basis. As a group, analysts forecast that The Allstate Co. will post 15.15 earnings per share for the current fiscal year.

Allstate Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Friday, May 31st will be given a dividend of $0.92 per share. The ex-dividend date is Friday, May 31st. This represents a $3.68 annualized dividend and a dividend yield of 2.23%. Allstate’s dividend payout ratio is presently 81.24%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. HSBC upgraded shares of Allstate from a “hold” rating to a “buy” rating and upped their price objective for the stock from $158.00 to $190.00 in a report on Thursday, March 28th. The Goldman Sachs Group lifted their price objective on Allstate from $164.00 to $195.00 and gave the company a “buy” rating in a research note on Monday, March 25th. Roth Mkm boosted their price objective on Allstate from $175.00 to $200.00 and gave the company a “buy” rating in a report on Monday, April 8th. StockNews.com cut Allstate from a “strong-buy” rating to a “buy” rating in a report on Monday, June 3rd. Finally, UBS Group boosted their price target on shares of Allstate from $171.00 to $185.00 and gave the stock a “buy” rating in a research note on Monday, February 12th. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $174.59.

Insider Activity at Allstate

In other news, insider John E. Dugenske sold 31,000 shares of Allstate stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the sale, the insider now owns 63,731 shares in the company, valued at $10,847,016.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.80% of the company’s stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.